Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for September 14th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 14th:

The Michaels Companies, Inc. (MIK - Free Report) : This arts and crafts specialty retail stores owner has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 68% over the last 60 days.

The Michaels Companies’ shares gained 50.6% over the last one month compared with the S&P 500’s growth of 1.4%. The company possesses a Momentum Score of A.

RH (RH - Free Report) : This retailer of home furnishings has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 78% over the last 60 days.

RH Price and Consensus

RH Price and Consensus

RH price-consensus-chart | RH Quote

 

RH’s shares gained 27% over the last one month. The company possesses a Momentum Score of A.

RH Price

RH Price

RH price | RH Quote

 

Dycom Industries, Inc. (DY - Free Report) : This specialty contracting services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 53.9% over the last 60 days.

Dycom Industries’ shares gained 48.7% over the last one month. The company possesses a Momentum Score of A.

Crocs, Inc. (CROX - Free Report) : This casual lifestyle footwear and accessories provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Crocs, Inc. Price and Consensus

Crocs, Inc. Price and Consensus

Crocs, Inc. price-consensus-chart | Crocs, Inc. Quote

 

Crocs’ shares gained 23.1% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


RH (RH) - free report >>

The Michaels Companies, Inc. (MIK) - free report >>

Dycom Industries, Inc. (DY) - free report >>

Crocs, Inc. (CROX) - free report >>